Trial IRCT20100228003449N27
Publication Rahmani H, Int Immunopharmacol, 2020
Primary outcome on the report: Time to clinical improvement

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.